Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Classical hematology 1

Conditions

Neoplasms 3Venous Thromboembolism 2Urinary Bladder Neoplasms 1Sarcoma 1Rectal Diseases 1Prostatic Neoplasms 1Polycythemia Vera 1Ovarian Neoplasms 1Neoplasms by Site 1Myeloproliferative Disorders 1Intestinal Neoplasms 1Intestinal Diseases 1Hematuria 1Hematoma 1Gastrointestinal Neoplasms 1Gastrointestinal Hemorrhage 1Gastrointestinal Diseases 1Endometrial Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Colorectal Neoplasms 1Colonic Diseases 1Bone Neoplasms 1Barrett Esophagus 1

Interventions

anlotinib 1Tranexamic Acid 1Indocyanine Green 1Ifosfamide 1Hyperbaric Oxygenation 1Enoxaparin 1Doxorubicin 1Brachytherapy 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Sarcoma × Aspirin × Clear all
NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Massachusetts General Hospital

Phase 4 Enrolling by invitation
2,868 enrolled
Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡